1. Volume 150, Issue 3, Pages 471-477 (September 2018)
Tumor Treating Fields in combination with paclitaxel in recurrent ovarian carcinoma: Results of the INNOVATE pilot study 
Ignace Vergote, Roger von Moos, Luis Manso, Els Van Nieuwenhuysen, Nicole Concin, Cristiana Sessa 
Gynecologic Oncology 
Volume 150, Issue 3, Pages (September 2018)
DOI: /j.ygyno
Copyright © 2018 The Authors Terms and Conditions

2. Fig. 1
The NovoTTF-100 L(O) System is a portable medical device delivering alternating electric fields to the pelvis/abdomen using 4 transducer arrays. The System can be portable when operated using a battery, allowing normal daily activities. The model presented is an actor and not a patient.
Gynecologic Oncology  , DOI: ( /j.ygyno )
Copyright © 2018 The Authors Terms and Conditions

3. Fig. 2 Progression free survival results of the INNOVATE Study
Kaplan-Mayer curves for the Intent-to-treat population. The median PFS was 8.9 months (95% CI 4.7, NA).
Gynecologic Oncology  , DOI: ( /j.ygyno )
Copyright © 2018 The Authors Terms and Conditions

4. Fig. 3 Overall survival results of the INNOVATE Study.
Kaplan-Mayer curves for the Intent-to-treat population the median OS was not reached (95% CI 10.2, NA).
Gynecologic Oncology  , DOI: ( /j.ygyno )
Copyright © 2018 The Authors Terms and Conditions